As of 2025-05-25, the EV/EBITDA ratio of AIM ImmunoTech Inc (AIM) is -0.26. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AIM's latest enterprise value is 7.21 mil USD. AIM's TTM EBITDA according to its financial statements is -27.48 mil USD. Dividing these 2 quantities gives us the above AIM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-05-09 | -0.27 |
| 2025-05-08 | -0.27 |
| 2025-05-07 | -0.29 |
| 2025-05-06 | -0.27 |
| 2025-05-05 | -0.26 |
| 2025-05-02 | -0.24 |
| 2025-05-01 | -0.23 |
| 2025-04-30 | -0.22 |
| 2025-04-29 | -0.23 |
| 2025-04-28 | -0.19 |
| 2025-04-25 | -0.21 |
| 2025-04-24 | -0.21 |
| 2025-04-23 | -0.15 |
| 2025-04-22 | -0.14 |
| 2025-04-21 | -0.14 |
| 2025-04-17 | -0.14 |
| 2025-04-16 | -0.14 |
| 2025-04-15 | -0.14 |
| 2025-04-14 | -0.13 |
| 2025-04-11 | -0.13 |
| 2025-04-10 | -0.12 |
| 2025-04-09 | -0.12 |
| 2025-04-08 | -0.15 |
| 2025-04-07 | -0.15 |
| 2025-04-04 | -0.26 |
| 2025-04-03 | -0.31 |
| 2025-04-02 | -0.32 |
| 2025-04-01 | -0.32 |
| 2025-03-31 | -0.32 |
| 2025-03-28 | -0.32 |
| 2025-03-27 | -0.33 |
| 2025-03-26 | -0.33 |
| 2025-03-25 | -0.35 |
| 2025-03-24 | -0.36 |
| 2025-03-21 | -0.36 |
| 2025-03-20 | -0.33 |
| 2025-03-19 | -0.32 |
| 2025-03-18 | -0.31 |
| 2025-03-17 | -0.31 |
| 2025-03-14 | -0.31 |
| 2025-03-13 | -0.31 |
| 2025-03-12 | -0.32 |
| 2025-03-11 | -0.32 |
| 2025-03-10 | -0.33 |
| 2025-03-07 | -0.34 |
| 2025-03-06 | -0.34 |
| 2025-03-05 | -0.34 |
| 2025-03-04 | -0.32 |
| 2025-03-03 | -0.31 |
| 2025-02-28 | -0.35 |